Wednesday, October 7, 2026

Fixed Income Trading

2 articles

30-Year Treasury Yields Breach 5% as Bond Markets Flash Global Fiscal Warning

30-Year Treasury Yields Breach 5% as Bond Markets Flash Global Fiscal Warning

30-year U.S. Treasury yields have broken above 5% and UK gilt yields have hit their highest levels since the 1990s, signaling a synchronized global bond market selloff. Persistent inflation driven by the Iran conflict and tariff uncertainty—compounding $857 in added annual gasoline costs for American households—is colliding with record sovereign debt loads and an impending Fed leadership transition. Diplomatic progress from the Trump-Xi summit and U.S.-China tariff reductions provides partial re

LM Salvado•
Treasury 30-Year Yields Cross 5%, UK Gilts Hit 1990s Highs — The Bond Revolt Traders Must Watch

Treasury 30-Year Yields Cross 5%, UK Gilts Hit 1990s Highs — The Bond Revolt Traders Must Watch

30-year Treasury yields have crossed 5% and UK gilts are trading at levels last seen in the 1990s, signaling a structural inflation regime rather than a cyclical episode. CPI holds at 3.8% with services inflation above 3% annually, compounded by the Iran war adding $857 to Americans' average gasoline costs in 2026. Jerome Powell's departure has created a Fed leadership vacuum that amplifies market uncertainty at the worst possible moment.

LM Salvado•
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Obesity and Immunology Readouts, Big Pharma M&A and AI-Designed Drugs Converge Into a Q4 2026 Catalyst Wave
Late-stage data and deal activity are clustering ahead of Q4 2026. Novo Nordisk's CagriSema won Best Abstract at EASD 2026 for its brain and body (fMRI/MRI) data, Lilly showed ADtouch results for EBGLYSS and agreed to buy Merida Biosciences for $2.9B, and Merck's tulisokibart hit its Phase 2b endpoints. A key regulatory catalyst follows: the FDA PDUFA date for the ivonescimab BLA on 2026-11-14. AI-designed rentosertib showing anti-aging effects adds a speculative AI-drug-discovery thread, while QAIAx's microcities trial and QIII pilot (planned 2027-01-01) are peripheral, forecast-only items.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,351 source documents archived
Query this data → isubstrate.com